Profil
Johannes Müller was the founder of Berlin Heals Holding AG, where he held the title of Chairman.
He founded the company in 2014.
Dr. Müller is also the founder of Berlin Cures GmbH, Berlin Cures Holding AG.
Currently, he is the Co-Chief Executive Officer at Berlin Heals GmbH.
In the past, he worked as the Director of Research & Development at Berlin Heart GmbH.
Postes actifs de Johannes Müller
| Sociétés | Poste | Début |
|---|---|---|
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Fondateur | - |
Berlin Heals GmbH
 Berlin Heals GmbH Medical SpecialtiesHealth Technology Berlin Heals GmbH is a life science company that was founded in 2014 with the mission to develop its proprietary c-mic technology to treat heart failure. The company is based in Berlin, Germany, and has subsidiaries in Switzerland. The German company has developed a novel implantable electroceutical device called "c-mic," which is a small implantable device that propagates reverse remodeling of the cardiac muscle tissue. The c-mic device is a breakthrough near-curative treatment for patients with systematic and refractory heart failure. The company intends to test the efficacy of its technology with patients suffering from heart failure with preserved ejection fractions (HFPEF-patients). The CEOs of the company are Peter Goettel and Johannes Müller. | Directeur Général | - |
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Fondateur | - |
Anciens postes connus de Johannes Müller
| Sociétés | Poste | Fin |
|---|---|---|
Berlin Heals Holding AG
 Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Fondateur | - |
Berlin Heart GmbH
 Berlin Heart GmbH Medical SpecialtiesHealth Technology Berlin Heart AG develops, manufactures and markets mechanical cardiac support systems. Its systems are used as life-savers for persons with a severely diseased heart. Its products INCOR, EXCOR, and EXCOR pediatric cover the range of medical indication for all ages, from the newborn to the adult. The company was founded in 2000 and is headquartered in Berlin, Germany. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Berlin Heart GmbH
Berlin Heart GmbH Medical SpecialtiesHealth Technology Berlin Heart AG develops, manufactures and markets mechanical cardiac support systems. Its systems are used as life-savers for persons with a severely diseased heart. Its products INCOR, EXCOR, and EXCOR pediatric cover the range of medical indication for all ages, from the newborn to the adult. The company was founded in 2000 and is headquartered in Berlin, Germany. | Health Technology |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Health Technology |
Berlin Heals GmbH
Berlin Heals GmbH Medical SpecialtiesHealth Technology Berlin Heals GmbH is a life science company that was founded in 2014 with the mission to develop its proprietary c-mic technology to treat heart failure. The company is based in Berlin, Germany, and has subsidiaries in Switzerland. The German company has developed a novel implantable electroceutical device called "c-mic," which is a small implantable device that propagates reverse remodeling of the cardiac muscle tissue. The c-mic device is a breakthrough near-curative treatment for patients with systematic and refractory heart failure. The company intends to test the efficacy of its technology with patients suffering from heart failure with preserved ejection fractions (HFPEF-patients). The CEOs of the company are Peter Goettel and Johannes Müller. | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Health Technology |
Berlin Heals Holding AG
Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Health Technology |
